Systemic Tofacitinib in Pediatric Alopecia Areata
August 2024
in “
Indian Journal of Dermatology Venereology and Leprology
”
Research cited in this study
2 / 2 results
research Tofacitinib for the Treatment of Alopecia Areata and Variants in Adolescents
In this retrospective review, tofacitinib treatment was associated with clinically significant hair regrowth in most adolescent patients with alopecia areata, though limitations suggest further studies are needed to confirm these findings.
research Safety and Efficacy of the JAK Inhibitor Tofacitinib Citrate in Patients with Alopecia Areata
This research overview highlights that although JAK inhibitors show promise as potential treatments for alopecia areata based on recent insights into the disease mechanism, their efficacy has not yet been thoroughly evaluated in a systematic manner.
Related Research
3 / 3 results
research Resistant Alopecia Areata Treated with Tofacitinib
In this case report, a young adult male with resistant alopecia areata showed nearly 90% hair regrowth after 3 months of treatment with tofacitinib, alongside biotin supplementation, without any side effects observed.
research Twenty Nail Dystrophy with Alopecia Areata in an Atopic Child
This case report describes a 6-year-old child with twenty nail dystrophy and alopecia areata of the scalp.
research Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib
This study reports significant hair regrowth in 11 patients with severe alopecia areata following longstanding treatment with oral tofacitinib and also highlights successful treatment using topical tofacitinib cream in one case.